Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.

Mager R, Daneshmand S, Evans CP, Palou J, Martínez-Salamanca JI, Master VA, McKiernan JM, Libertino JA, Haferkamp A; International Renal Cell Carcinoma-Venous Thrombus Consortium, Haferkamp A, Capitanio U, Carballido JA, Chantada V, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, González J, Hohenfellner M, Huang WC, Koppie TM, Libertino JA, Espinós EL, Lorentz A, Martínez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, O'Malley P, Pahernik S, Palou J, Moreno JL, Pruthi RS, Faba OR, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Tilki D, Vázquez-Martul D, Donoso CV, Vergho D, Wallen EM, Zigeuner R.

J Surg Oncol. 2016 Nov;114(6):764-768. doi: 10.1002/jso.24395. Epub 2016 Aug 26.

2.

The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and Germany.

Meyer C, Hansen J, Becker A, Schmid M, Pradel L, Strini K, Chromecki T, Jesche-Chromecki J, Fisch M, Zigeuner R, Chun FK.

Urol Int. 2016;96(3):330-6. doi: 10.1159/000442215. Epub 2015 Dec 24.

PMID:
26699625
3.

Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.

Becker A, Hickmann D, Hansen J, Meyer C, Rink M, Schmid M, Eichelberg C, Strini K, Chromecki T, Jesche J, Regier M, Randazzo M, Tilki D, Ahyai S, Dahlem R, Fisch M, Zigeuner R, Chun FK.

Eur J Surg Oncol. 2016 Mar;42(3):419-25. doi: 10.1016/j.ejso.2015.09.023. Epub 2015 Oct 23.

PMID:
26520403
4.

Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.

Nguyen HG, Tilki D, Dall'Era MA, Durbin-Johnson B, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Espinós EL, Mandel P, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.

J Urol. 2015 Aug;194(2):304-308. doi: 10.1016/j.juro.2015.02.2948. Epub 2015 Mar 19.

5.

Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.

Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Linares E, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Thieu W, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.

J Urol. 2015 Feb;193(2):436-42. doi: 10.1016/j.juro.2014.07.087. Epub 2014 Jul 22.

PMID:
25063493
6.

Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).

Martínez-Salamanca JI, Linares E, González J, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Nguyen HG, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Faba OR, Russo P, Shariat SF, Spahn M, Terrone C, Tilki D, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA.

Curr Urol Rep. 2014 May;15(5):404. doi: 10.1007/s11934-014-0404-7. Review.

PMID:
24682884
7.

Do young patients with renal cell carcinoma feature a distinct outcome after surgery? A comparative analysis of patient age based on the multinational CORONA database.

Aziz A, May M, Zigeuner R, Pichler M, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Fenske F, Sountoulides P, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Wieland WF, Salzano L, Lotrecchiano G, Waidelich R, Stief C, Brookman-May S; Members of the CORONA Project and the Young Academic Urologists Renal Cancer Group.

J Urol. 2014 Feb;191(2):310-5. doi: 10.1016/j.juro.2013.08.021. Epub 2013 Aug 20.

PMID:
23973516
8.

Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.

Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.

Eur Urol. 2014 Sep;66(3):577-83. doi: 10.1016/j.eururo.2013.06.048. Epub 2013 Jul 10.

PMID:
23871402
9.

[Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database].

May M, Zigeuner R, Aziz A, Cindolo L, Gilfrich C, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Hoschke B, Dalpiaz O, Stoltze A, Fenske F, Fritsche HM, Chromecki T, Lebentrau S, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief CG, Brookman-May S; Mitglieder des "CORONA projects"; Projektgruppe "Young Academic Urologists Renal Cancer Group" der European Association of Urology (EAU).

Urologe A. 2014 Feb;53(2):228-35. doi: 10.1007/s00120-013-3237-y. German.

PMID:
23836364
10.

Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis.

Brookman-May S, May M, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Feciche B, Coman I, Truss M, Pahernik S, Wirth MP, Zastrow S, Dalpiaz O, Fenske F, Waidelich R, Stief C, Gunia S; Members of the CORONA Project.

Clin Genitourin Cancer. 2013 Dec;11(4):465-70. doi: 10.1016/j.clgc.2013.04.026. Epub 2013 Jun 29.

PMID:
23820063
11.

Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma.

Hutterer GC, Pichler M, Chromecki TF, Strini KA, Klatte T, Pummer K, Remzi M, Mannweiler S, Zigeuner R.

Histopathology. 2013 Sep;63(3):309-15. doi: 10.1111/his.12163. Epub 2013 Jun 26.

PMID:
23802739
12.

Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.

May M, Aziz A, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Stoltze A, Fenske F, Fritsche HM, Figenshau RS, Madison K, Sánchez-Chapado M, Martin Mdel C, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief C, Brookman-May S; Members of the CORONA project the Young Academic Urologists Renal Cancer Group.

World J Urol. 2013 Oct;31(5):1073-80. doi: 10.1007/s00345-013-1071-x. Epub 2013 Apr 9.

PMID:
23568445
13.

Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study.

Cindolo L, Chiodini P, Brookman-May S, De Cobelli O, May M, Squillacciotti S, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Wirth MP, Dalpiaz O, Chromecki TF, Shariat SF, Sanchez-Chapado M, Santiago Martin Mdel C, Rocco B, Salzano L, Lotrecchiano G, Berardinelli F, Schips L.

BJU Int. 2013 Sep;112(5):578-84. doi: 10.1111/j.1464-410X.2012.11670.x. Epub 2013 Mar 7.

14.

Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.

May M, Ficarra V, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Burger M, Gunia S, Feciche B, Wenzl V, Aziz A, Chun F, Becker A, Pahernik S, Simeone C, Longo N, Zucchi A, Antonelli A, Mirone V, Stief C, Novara G, Brookman-May S; CORONA and SATURN projects; Young Academic Urologists Renal Cancer Group.

J Urol. 2013 Aug;190(2):458-63. doi: 10.1016/j.juro.2013.02.035. Epub 2013 Feb 19.

PMID:
23434943
15.

Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.

Pichler M, Hutterer GC, Stoeckigt C, Chromecki TF, Stojakovic T, Golbeck S, Eberhard K, Gerger A, Mannweiler S, Pummer K, Zigeuner R.

Br J Cancer. 2013 Mar 5;108(4):901-7. doi: 10.1038/bjc.2013.28. Epub 2013 Feb 5.

16.

Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series.

Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Groselj-Strele A, Pummer K, Zigeuner R.

BJU Int. 2013 Apr;111(4 Pt B):E191-5. doi: 10.1111/j.1464-410X.2012.11584.x. Epub 2012 Oct 26.

17.

Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.

Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Groselj-Strele A, Hoefler G, Pummer K, Zigeuner R.

Histopathology. 2013 Jan;62(2):237-46. doi: 10.1111/his.12001. Epub 2012 Sep 28.

PMID:
23020176
18.

Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma.

Pichler M, Hutterer GC, Chromecki TF, Pummer K, Mannweiler S, Zigeuner R.

Histopathology. 2013 Jan;62(2):219-28. doi: 10.1111/j.1365-2559.2012.04328.x. Epub 2012 Sep 7.

PMID:
22957986
19.

Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.

Brookman-May S, May M, Ficarra V, Kainz MC, Kampel-Kettner K, Kohlschreiber S, Wenzl V, Schneider M, Burger M, Wieland WF, Otto W, Tilki D, Gilfrich C, Hohenfellner M, Pahernik S, Chromecki TF, Stief C, Zigeuner R; Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project.

World J Urol. 2013 Oct;31(5):1309-16. doi: 10.1007/s00345-012-0931-0. Epub 2012 Aug 19.

PMID:
22903790
20.

Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.

Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF.

Eur Urol. 2013 Nov;64(5):837-45. doi: 10.1016/j.eururo.2012.07.026. Epub 2012 Jul 20.

PMID:
22877503

Supplemental Content

Loading ...
Support Center